Matthew Killeen
Chief Tech/Sci/R&D Officer at RENOVACOR, INC.
Profile
Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd.
Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.
Matthew Killeen active positions
| Companies | Position | Start |
|---|---|---|
| RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 01/09/2021 |
CREAGRI, Inc.
 CREAGRI, Inc. Food RetailRetail Trade CREAGRI, Inc. develops and supplies antioxidant polyphenols. Its products are used for functional foods, health and dietary supplements. The company was founded by Roberto Crea in 1998 and is headquartered in Hayward, CA. | Corporate Officer/Principal | 12/05/2011 |
| Sudden Cardiac Arrest Foundation | Director/Board Member | - |
Former positions of Matthew Killeen
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Corporate Officer/Principal | - |
Training of Matthew Killeen
| University of Cambridge | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private companies | 4 |
|---|---|
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
CREAGRI, Inc.
CREAGRI, Inc. Food RetailRetail Trade CREAGRI, Inc. develops and supplies antioxidant polyphenols. Its products are used for functional foods, health and dietary supplements. The company was founded by Roberto Crea in 1998 and is headquartered in Hayward, CA. | Retail Trade |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
| Sudden Cardiac Arrest Foundation |
- Stock Market
- Insiders
- Matthew Killeen
